The Future of the Modern Contraceptive Method Mix: Innovation in Contraceptive Access Strategy
2023
FP2030 and the CTI Exchange, in partnership with Population Council, PSI, RHSC, and FHI 360, hosted an exploration of innovative contraceptive technology, including the Nestorone®/Testosterone transdermal gel, biodegradable implants, and multipurpose prevention technologies. This webinar shared a vision for what a user-led, context-appropriate, and gender inclusive contraceptive method mix could look like for the next generation of potential contraceptive users.